We examined whether influenza vaccination affects 1-year risk of myocardial infarction, stroke, heart failure, pneumonia, and death among intensive care unit (ICU) survivors aged ≥ 65 years.
Danish Intensive Care Database data on all elderly ( ≥ 65 years) patients hospitalized in Danish ICUs in the period 2005–2015, and subsequently discharged, were linked with data from other medical registries, including data on uptake of the seasonal influenza vaccine. We computed these patients’ 1-year risk of hospitalization for myocardial infarction, stroke, heart failure, or pneumonia, and their 1-year risk of all-cause mortality. Hazard ratios (HRs) with 95% confidence intervals (CIs) were computed using Cox proportional hazards regression, with adjustment and propensity score matching applied to handle confounding.
The study included 89,818 ICU survivors. The influenza vaccinated patients (n = 34,871, 39%) were older, had more chronic diseases, and used more prescription medications than the unvaccinated patients. Adjusted 1-year mortality was decreased among the vaccinated versus the unvaccinated patients (19.3% versus 18.8%; adjusted HR, 0.92; 95% CI 0.89–0.95). Influenza vaccination was also associated with a decreased risk of stroke (adjusted HR, 0.84; 95% CI 0.78–0.92), but only a small, non-significantly decreased risk of myocardial infarction (adjusted HR, 0.93; 95% CI 0.83–1.03). There was no association between vaccination and subsequent hospitalization for heart failure or pneumonia. Propensity score matched analyses confirmed these findings.
Compared with the unvaccinated ICU survivors, the influenza vaccinated ICU survivors had a lower 1-year risk of stroke and a lower 1-year risk of death, whereas no substantial association was observed for the risk of hospitalization for myocardial infarction, heart failure, or pneumonia. Our findings support influenza vaccination of individuals aged ≥ 65 years.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Mankowski RT, Yende S, Angus DC (2019) Long-term impact of sepsis on cardiovascular health. Intensive Care Med 45:78–81. https://doi.org/10.1007/s00134-018-5173-1
Prescott HC, Angus DC (2018) Enhancing recovery from sepsis: a review. JAMA 319:62–75. https://doi.org/10.1001/jama.2017.17687
Baldwin MR (2015) Measuring and predicting long-term outcomes in older survivors of critical illness. Minerva Anestesiol 81:650–661
Wunsch H, Guerra C, Barnato AE, Angus DC, Li G, Linde-Zwirble WT (2010) Three-year outcomes for Medicare beneficiaries who survive intensive care. JAMA 303:849–856. https://doi.org/10.1001/jama.2010.216
Moitra VK, Guerra C, Linde-Zwirble WT, Wunsch H (2016) Relationship between ICU length of stay and long-term mortality for elderly ICU survivors. Crit Care Med 44:655–662. https://doi.org/10.1097/ccm.0000000000001480
Williams TA, Dobb GJ, Finn JC, Knuiman MW, Geelhoed E, Lee KY, Webb SA (2008) Determinants of long-term survival after intensive care. Crit Care Med 36:1523–1530. https://doi.org/10.1097/ccm.0b013e318170a405
Christiansen CF, Christensen S, Johansen MB, Larsen KM, Tonnesen E, Sorensen HT (2011) The impact of pre-admission morbidity level on 3-year mortality after intensive care: a Danish cohort study. Acta Anaesthesiol Scand 55:962–970. https://doi.org/10.1111/j.1399-6576.2011.02480.x
Grijalva CG, Zhu Y, Williams DJ, Self WH, Ampofo K, Pavia AT, Stockmann CR, McCullers J, Arnold SR, Wunderink RG, Anderson EJ, Lindstrom S, Fry AM, Foppa IM, Finelli L, Bramley AM, Jain S, Griffin MR, Edwards KM (2015) Association Between Hospitalization With Community-Acquired Laboratory-Confirmed Influenza Pneumonia and Prior Receipt of Influenza Vaccination. JAMA 314:1488–1497. https://doi.org/10.1001/jama.2015.12160
Chertow DS, Memoli MJ (2013) Bacterial coinfection in influenza: a grand rounds review. JAMA 309:275–282. https://doi.org/10.1001/jama.2012.194139
Warren-Gash C, Smeeth L, Hayward AC (2009) Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review. Lancet Infect Dis 9:601–610. https://doi.org/10.1016/s1473-3099(09)70233-6
Warren-Gash C, Hayward AC, Hemingway H, Denaxas S, Thomas SL, Timmis AD, Whitaker H, Smeeth L (2012) Influenza infection and risk of acute myocardial infarction in England and Wales: a CALIBER self-controlled case series study. J Infect Dis 206:1652–1659. https://doi.org/10.1093/infdis/jis597
Dalager-Pedersen M, Sogaard M, Schonheyder HC, Nielsen H, Thomsen RW (2014) Risk for myocardial infarction and stroke after community-acquired bacteremia: a 20-year population-based cohort study. Circulation 129:1387–1396. https://doi.org/10.1161/circulationaha.113.006699
Jackson ML, Nelson JC, Weiss NS, Neuzil KM, Barlow W, Jackson LA (2008) Influenza vaccination and risk of community-acquired pneumonia in immunocompetent elderly people: a population-based, nested case-control study. Lancet 372:398–405. https://doi.org/10.1016/s0140-6736(08)61160-5
Kwong JC, Schwartz KL, Campitelli MA, Chung H, Crowcroft NS, Karnauchow T, Katz K, Ko DT, McGeer AJ, McNally D, Richardson DC, Rosella LC, Simor A, Smieja M, Zahariadis G, Gubbay JB (2018) Acute myocardial infarction after laboratory-confirmed influenza infection. N Engl J Med 378:345–353. https://doi.org/10.1056/nejmoa1702090
Jorgensen P, Mereckiene J, Cotter S, Johansen K, Tsolova S, Brown C (2018) How close are countries of the WHO European region to achieving the goal of vaccinating 75% of key risk groups against influenza? Results from national surveys on seasonal influenza vaccination programmes, 2008/2009 to 2014/2015. Vaccine 36:442–452. https://doi.org/10.1016/j.vaccine.2017.12.019
Udell JA, Zawi R, Bhatt DL, Keshtkar-Jahromi M, Gaughran F, Phrommintikul A, Ciszewski A, Vakili H, Hoffman EB, Farkouh ME, Cannon CP (2013) Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis. JAMA 310:1711–1720. https://doi.org/10.1001/jama.2013.279206
Clar C, Oseni Z, Flowers N, Keshtkar-Jahromi M, Rees K (2015) Influenza vaccines for preventing cardiovascular disease. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.cd005050.pub3
Lee KR, Bae JH, Hwang IC, Kim KK, Suh HS, Ko KD (2017) Effect of influenza vaccination on risk of stroke: a systematic review and meta-analysis. Neuroepidemiology 48:103–110. https://doi.org/10.1159/000478017
Eurich DT, Marrie TJ, Johnstone J, Majumdar SR (2008) Mortality reduction with influenza vaccine in patients with pneumonia outside “flu” season: pleiotropic benefits or residual confounding? Am J Respir Crit Care Med 178:527–533. https://doi.org/10.1164/rccm.200802-282oc
Demirdogen Cetinoglu E, Uzaslan E, Sayiner A, Cilli A, Kilinc O, Sakar Coskun A, Hazar A, Kokturk N, Filiz A, Polatli M, Group TS (2017) Pneumococcal and influenza vaccination status of hospitalized adults with community acquired pneumonia and the effects of vaccination on clinical presentation. Hum Vaccin Immunother 13:2072–2077. https://doi.org/10.1080/21645515.2017.1339851
Ting EEK, Sander B, Ungar WJ (2017) Systematic review of the cost-effectiveness of influenza immunization programs. Vaccine 35:1828–1843. https://doi.org/10.1016/j.vaccine.2017.02.044
Demicheli V, Jefferson T, Di Pietrantonj C, Ferroni E, Thorning S, Thomas RE, Rivetti A (2018) Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev 2(5):5–9
Christiansen CF, Moller MH, Nielsen H, Christensen S (2016) The Danish Intensive Care Database. Clin Epidemiol 8:525–530. https://doi.org/10.2147/clep.s99476
Schmidt M, Pedersen L, Sorensen HT (2014) The Danish Civil Registration System as a tool in epidemiology. Eur J Epidemiol 29:541–549. https://doi.org/10.1007/s10654-014-9930-3
Andersen JS, Olivarius NF, Krasnik A (2011) The Danish National Health Service Register. Scand J Public Health 39:34–37. https://doi.org/10.1177/1403494810394718
Schmidt M, Schmidt SA, Sandegaard JL, Ehrenstein V, Pedersen L, Sorensen HT (2015) The Danish National Patient Registry: a review of content, data quality, and research potential. Clin Epidemiol 7:449–490. https://doi.org/10.2147/clep.s91125
Lipsitch M, Tchetgen Tchetgen E, Cohen T (2010) Negative controls: a tool for detecting confounding and bias in observational studies. Epidemiology 21:383–388. https://doi.org/10.1097/ede.0b013e3181d61eeb
Needham DM, Scales DC, Laupacis A, Pronovost PJ (2005) A systematic review of the Charlson comorbidity index using Canadian administrative databases: a perspective on risk adjustment in critical care research. J Crit Care 20:12–19. https://doi.org/10.1016/j.jcrc.2004.09.007
Thygesen SK, Christiansen CF, Christensen S, Lash TL, Sorensen HT (2011) The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of Patients. BMC Med Res Methodol 11:83. https://doi.org/10.1186/1471-2288-11-83
Johannesdottir SA, Horvath-Puho E, Ehrenstein V, Schmidt M, Pedersen L, Sorensen HT (2012) Existing data sources for clinical epidemiology: The Danish National Database of Reimbursed Prescriptions. Clin Epidemiol 4:303–313. https://doi.org/10.2147/clep.s37587
Andersen PK, Geskus RB, de WT, Putter H (2012) Competing risks in epidemiology: possibilities and pitfalls. Int J Epidemiol 41:861–870. https://doi.org/10.1093/ije/dyr213
Sturmer T, Joshi M, Glynn RJ, Avorn J, Rothman KJ, Schneeweiss S (2006) A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methods. J Clin Epidemiol 59:437–447. https://doi.org/10.1016/j.jclinepi.2005.07.004
Austin PC (2007) Propensity-score matching in the cardiovascular surgery literature from 2004 to 2006: a systematic review and suggestions for improvement. J Thorac Cardiovasc Surg 134:1128–1135. https://doi.org/10.1016/j.jtcvs.2007.07.021
Harder KM, Andersen PH, Bahr I, Nielsen LP, Ethelberg S, Glismann S, Molbak K (2011) Electronic real-time surveillance for influenza-like illness: experience from the 2009 influenza A(H1N1) pandemic in Denmark. Euro Surveill. https://doi.org/10.2807/ese.16.03.19767-en
Nichols MK, Andrew MK, Ye L, Hatchette TF, Ambrose A, Boivin G, Bowie W, Dos Santos G, Elsherif M, Green K, Haguinet F, Katz K, Leblanc J, Loeb M, MacKinnon-Cameron D, McCarthy A, McElhaney JE, McGeer A, Powis J, Richardson D, Semret M, Sharma R, Shinde V, Smyth D, Trottier S, Valiquette L, Webster D, McNeil SA, Serious Outcomes Surveillance Network of the Canadian Immunization Research N (2018) The Impact of Prior Season Vaccination on Subsequent Influenza Vaccine Effectiveness (VE) to Prevent Influenza-Related Hospitalizations over Four Influenza Seasons in Canada. Clin Infect Dis. https://doi.org/10.1093/cid/ciy1009
Sundboll J, Adelborg K, Munch T, Froslev T, Sorensen HT, Botker HE, Schmidt M (2016) Positive predictive value of cardiovascular diagnoses in the Danish National Patient Registry: a validation study. BMJ open 6:e012832. https://doi.org/10.1136/bmjopen-2016-012832
Jackson LA, Jackson ML, Nelson JC, Neuzil KM, Weiss NS (2006) Evidence of bias in estimates of influenza vaccine effectiveness in seniors. Int J Epidemiol 35:337–344. https://doi.org/10.1093/ije/dyi274
Hellfritzsch M, Thomsen RW, Baggesen LM, Larsen FB, Sorensen HT, Christiansen CF (2017) Lifestyle, socioeconomic characteristics, and medical history of elderly persons who receive seasonal influenza vaccination in a tax-supported healthcare system. Vaccine 35:2396–2403. https://doi.org/10.1016/j.vaccine.2017.03.040
Dormuth CR, Patrick AR, Shrank WH, Wright JM, Glynn RJ, Sutherland J, Brookhart MA (2009) Statin adherence and risk of accidents: a cautionary tale. Circulation 119:2051–2057. https://doi.org/10.1161/circulationaha.108.824151
Benn CS, Netea MG, Selin LK, Aaby P (2013) A small jab—a big effect: nonspecific immunomodulation by vaccines. Trends Immunol 34:431–439. https://doi.org/10.1016/j.it.2013.04.004
Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, Fonseca F, Nicolau J, Koenig W, Anker SD, Kastelein JJP, Cornel JH, Pais P, Pella D, Genest J, Cifkova R, Lorenzatti A, Forster T, Kobalava Z, Vida-Simiti L, Flather M, Shimokawa H, Ogawa H, Dellborg M, Rossi PRF, Troquay RPT, Libby P, Glynn RJ, Group CT (2017) Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease. N Engl J Med 377:1119–1131. https://doi.org/10.1056/nejmoa1707914
This research received financial support from the Danish Medical Research Council (Grant 271-05-0511), from the Aarhus University Research Foundation, and from the Program for Clinical Research Infrastructure (PROCRIN) established by the Lundbeck Foundation and the Novo Nordisk Foundation and administered by the Danish Regions. The funding agencies had no role in the design, conduct, analysis, or reporting of this study.
Conflicts of interest
The authors declare that they have no conflicts of interest.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
About this article
Cite this article
Christiansen, C.F., Thomsen, R.W., Schmidt, M. et al. Influenza vaccination and 1-year risk of myocardial infarction, stroke, heart failure, pneumonia, and mortality among intensive care unit survivors aged 65 years or older: a nationwide population-based cohort study. Intensive Care Med 45, 957–967 (2019). https://doi.org/10.1007/s00134-019-05648-4
- Cardiovascular diseases
- Cohort studies
- Influenza vaccines
- Intensive care